23.09.2016 Views

SPECTRUM PHARMATECH CONSULTANTS - NEW COMPANY PROFILE

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

20<br />

CELEBRATING<br />

Company Profile<br />

Think... Challenge...Explore...Create...Exceed...


Contents<br />

About Us 1<br />

Field of Expertise 4<br />

Our Capabilities 5<br />

Our Clients 7<br />

Case Studies 11<br />

Project Coverage 13


ABOUT US<br />

<strong>SPECTRUM</strong> PharmaTECH Consultants Pvt. Ltd. (<strong>SPECTRUM</strong>) is a<br />

knowledge based, fully integrated Architectural and Engineering firm<br />

providing state of art solutions to clients in the pharmaceutical, biotech,<br />

food, beverage and cosmetic industries worldwide, satisfying the strictest<br />

regulatory requirements.<br />

Started in 1995, <strong>SPECTRUM</strong> has been offering one-stop Engineering<br />

Solutions to APIs, Finished Dosage Forms (OSD, Semi Solids, and Aseptic<br />

Products.), Analytical and Microbiological Laboratories, Pilot Plants, R&D<br />

Centres, High Potent Products, Herbal Medicines, Cosmetics etc.<br />

.<br />

VISION:<br />

To be a leading Architectural and Engineering Consultant<br />

providing integrated services from Laboratory to Consumer.<br />

To achieve our vision we will strive to:<br />

<br />

<br />

<br />

Provide reliable professional services to our clients<br />

Forge mutually beneficial and lasting relationships with our clients and<br />

partners<br />

Develop our staff to deliver the highest quality of service and to seek<br />

innovative and creative approaches to problem solving.<br />

1<br />

<strong>SPECTRUM</strong> employs more than 80 technical professionals and offers a<br />

broad range of highly experienced and motivated engineers with hands on<br />

experience and technical expertise in their chosen domains.<br />

With a strong history of innovation and technological advancement, our<br />

experts seek out not only the most up to date equipment but also the most<br />

logical solutions for our clients.<br />

<strong>SPECTRUM</strong>'s designs are based on foresight and experience, resulting in GMP<br />

compliance by design.


Advantage <strong>SPECTRUM</strong><br />

<strong>SPECTRUM</strong> has a track record of working with leading Indian and Multinational clients. One can count on <strong>SPECTRUM</strong><br />

to deliver quality advice based on a thorough market research, current trends and future scenario; the best and most<br />

practical designs; track schedules and monitor construction to produce the most suitable, cost effective solutions within<br />

fixed time-lines.<br />

Single Source Reliability<br />

You can count on <strong>SPECTRUM</strong> to deliver quality designs, track schedules &<br />

monitor construction as an agent on your behalf.<br />

Single source responsibility means the firm will fix a problem when it shows<br />

up. Spectrum provides Single Point Reliability, which means that we will<br />

avoid having most of those problems in the first place.<br />

ETHICS:<br />

<strong>SPECTRUM</strong> lays great emphasis on ethics and honesty. What<br />

you get is a fair, unbiased and objective appraisal of the<br />

market.<br />

Commitment<br />

<strong>SPECTRUM</strong> is committed to providing their clients with the highest possible level of architectural, planning, design,<br />

engineering and validation services.<br />

Our Quality policy<br />

Ensuring customer satisfaction through leadership in engineering, technology and management services.<br />

Spectrum is committed to understand, meet and when possible exceed our Customer's expectations through continuous<br />

improvement of our working methods, systems and processes. We are dedicated to delivering defect-free services to all<br />

our customers on time - every time.<br />

Passion for excellence, obsession with customer satisfaction, integrity in our commitments and mutual respect in our day to<br />

day working guide us to fulfilling this.<br />

2


Sustainability<br />

<strong>SPECTRUM</strong> gives prime importance to energy efficient designs and undertakes strict measures to protect the<br />

environment. All our designs by policy are zero discharge facilities (unless specifically requested otherwise) that use all<br />

the waste water generated on site for internal usage.<br />

We take design decisions that help in consumption of optimum energy required only and no more.<br />

We also recognize that land is the most valuable asset today. We ensure during the conceptualization stage itself that we<br />

optimize its usage and always strive for ability to expand in future.<br />

Our Approach<br />

At <strong>SPECTRUM</strong> we have embraced the Project Cycle<br />

Approach. We participate and guide the Client through<br />

the project life cycle from concept design, basic and<br />

detailed engineering, undertake project management<br />

along with construction supervision to validation and<br />

start-up of the facility.<br />

We believe that as consultants we are but an extension<br />

of our clients. Each of our project team members not<br />

only aim but achieve client satisfaction.<br />

Hand<br />

Over<br />

Commissioning<br />

&<br />

Qualification<br />

Construction<br />

Procurement Assistance<br />

Basic & Detailed Engineering Design<br />

Concept Design and Master Planning<br />

You & We<br />

WE HELP YOU TO CONVERT<br />

YOUR PLANS FOR TODAY INTO<br />

A BETTER<br />

TOMORROW<br />

We recognize that our team is not the largest<br />

that you will come across, but we also know<br />

that you will be hard pressed to find a team<br />

more agile, responsive and flexible enough to<br />

accommodate your needs. We are engaged,<br />

c o m m u n i c a t i v e , c o l l a b o r a t i v e a n d<br />

committed.<br />

After all we are an extension of you.<br />

3


Field Of Expertise<br />

INDUSTRIES<br />

SERVED<br />

We provide complete project<br />

engineering services from concept<br />

to commissioning with in-house<br />

expertise for architectural, civil,<br />

structural, mechanical, HVAC,<br />

piping, water treatment, electrical,<br />

effluent treatment and fire and<br />

safety systems.<br />

We Follow<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

®<br />

Baseline Engineering guides published by ISPE<br />

ISO 14644 – Design of Clean Room & Associated<br />

Controlled Environments<br />

US FDA<br />

UK MHRA<br />

SOUTH AFRICAN MCC<br />

AUSTRALIAN TGA<br />

INDIAN SCHEDULE – M<br />

BRAZILIAN ANVISA<br />

WHO GMP<br />

DESIGN<br />

APPROACH<br />

FlexibleandComprehensive<br />

EnvironmentProtection<br />

SafetybyDesign<br />

CostEffectiveSolutions<br />

CustomizedEngineering<br />

UnderstandtheClient’sRequirements<br />

4


Our Capabilities<br />

We provide complete project engineering services from concept to commissioning with in-house expertise for<br />

architectural, civil, structural, mechanical, HVAC, piping and electrical engineering services. We are known in the<br />

Pharmaceutical Industry for the services we undertake including:<br />

Advisory/<br />

Master Planning<br />

Basis of<br />

Design<br />

Development<br />

Engineering<br />

Construction<br />

Qualification<br />

&<br />

Validation<br />

Pre-feasibility &<br />

Feasibility studies<br />

Master Planning &<br />

Conceptual design<br />

Site selection studies<br />

Tenant Search<br />

Benchmarking<br />

EU-GMP / FDA<br />

consulting<br />

Due Diligence &<br />

Audits<br />

General Planning or<br />

Engineering<br />

Technology<br />

Research<br />

Equipment Study &<br />

Procurement<br />

Design Development<br />

Civil & Architecture<br />

Expansion/Relocatio<br />

n/ Integration<br />

Planning<br />

Detailed Building<br />

Engineering including<br />

Architectural<br />

Civil<br />

Structural<br />

Process<br />

HVAC<br />

Electrical<br />

Mechanical & Piping<br />

Utilities<br />

Plumbing<br />

Instrumentation &<br />

Automation<br />

Fire & Safety<br />

Environmental<br />

Inter - Disciplinary<br />

Construction and<br />

Project<br />

Management<br />

Site management<br />

Construction<br />

Supervision<br />

Procurement<br />

Time Cost<br />

Estimation<br />

Bill Certification<br />

DQ / IQ / OQ<br />

GMP Risk analysis<br />

Computer system<br />

validation<br />

Cleaning validation<br />

Support services for<br />

process validation<br />

Validation<br />

Documentation<br />

From the very level of conceptualizing, <strong>SPECTRUM</strong> participates with and guides the Client through the project life cycle<br />

including assessment of project feasibility, master planning, architectural design, detailed engineering, risk and hazard<br />

assessment, construction management to validation and start up.<br />

We have a track of earning projects repetitively from world renowned national and international manufacturers like<br />

Glenmark, Dr. Reddy's, Johnson & Johnson, RPG Life Sciences, Sanzyme, OmniActive, Novartis etc. This is a testimony<br />

to the quality of service provided by us.<br />

5


End To End Solutions for Your Business<br />

<strong>SPECTRUM</strong> along with their<br />

associates offers its clients endto-end<br />

healthcare business<br />

solutions enabling you to surpass<br />

the short term as well as long term<br />

goals.<br />

Turnkey<br />

setting up<br />

State-of-the-art<br />

cGMP compliant<br />

facilities to<br />

manufacture the<br />

selected<br />

products.<br />

<br />

Technology<br />

Identify<br />

partners for<br />

sourcing of<br />

Techonology,<br />

APIs, Intermediates,<br />

Packaging material<br />

and Finished<br />

Products.<br />

Product Portfolio<br />

building by<br />

identifying right<br />

products with focus<br />

on growing therapy<br />

segments and<br />

molecules.<br />

End To End<br />

Solutions<br />

Recruitment<br />

Support<br />

recruitment of<br />

personnel for<br />

Operations.<br />

Market Potential<br />

Study for<br />

Domestic Sale &<br />

Exports.<br />

Weareproudofourability<br />

tocreateanddeliver<br />

bettersolutionstoourclients<br />

24<br />

6


Key Clients: International<br />

Acme, Bangladesh<br />

Beximco Pharmaceu cals,<br />

Bangladesh<br />

Ethiopian Pharmaceu cal<br />

Manufacturing (EPHARM), Ethiopia<br />

Geltech, Dubai<br />

Glenmark Pharmaceu cals, Brazil<br />

Glenmark Generics, Argen na<br />

Jizhong Pharma, China<br />

Pharmasyntez, Russia<br />

East Pharm, Russia<br />

Kusum Pharm, Ukraine<br />

Neapolis Laboratories, Tunisia<br />

Letap Pharmaceu cals, Ghana<br />

Medica Pharmaceu cals, Yemen<br />

Novast Laboratories, China<br />

Pharmax Pharmaceu cals, Dubai<br />

Polygon FZC, Turkmenistan<br />

Swiss Biogenics, Sri Lanka<br />

Ultra Pharma, Bangladesh<br />

A J Biologics, Malaysia<br />

BDA Life Science, Congo<br />

BIEM ILAC, Turkey<br />

7


Key Clients: Finished Dosage Forms<br />

Apex Laboratories<br />

Aurobindo Pharma<br />

AVN Ayurveda<br />

Dr. Reddys Laboratories<br />

Emmellen Biotech<br />

Famycare<br />

Glenmark Generics<br />

Glenmark Pharmaceu cals<br />

Helvoet Pharma<br />

Hygieia Biogenics<br />

Intas Pharmaceu cals<br />

IPCA Labs<br />

Korten Pharmaceu cals<br />

Kusum Healthcare<br />

M J Biopharm<br />

Mepro Pharmaceu cals<br />

MSN Laboratories<br />

Naprod Life Sciences<br />

Novar s Enterprises<br />

Orchid Healthcare<br />

Raichem Life Sciences (Shilpa<br />

Medicare)<br />

RPG Life Sciences<br />

Sandoz<br />

Sanzyme (Formerly known as<br />

Unisankyo)<br />

Shreya Life Sciences<br />

Wincoat Colours & Coa ngs<br />

8


Key Clients: Active Pharmaceutical Ingredients<br />

Alkem Laboratories<br />

Amrutanjan Healthcare<br />

BASF Coa ng (India)<br />

Dr. Reddy’s Labs<br />

Embio<br />

Enaltec Labs<br />

Fermenta Biotech<br />

Glenmark Generics<br />

Mac-Chem<br />

Navin Flourine Interna onal<br />

Omni Ac ve Health Technologies<br />

Reliance Life Sciences<br />

RPG Life Sciences<br />

Sterling Biotech<br />

Unimark Remedies<br />

Zydus Cadilla<br />

9


Key Clients: Biopharmaceuticals<br />

Biological E.<br />

Fermenta Biotech<br />

Kasiak Labs (Part of Bharat Serums<br />

and Vaccines Group)<br />

Sanzyme (Formerly known as<br />

Unisankyo Ltd.)<br />

Tex Biosciences<br />

Key Clients: Labs, R&D and Pilot Plants<br />

Wockhardt<br />

Ivax India<br />

Janssen Cilag<br />

Lupin<br />

Mankind Pharma<br />

Merck India<br />

Novar s Healthcare<br />

Promed Research Centre<br />

Sandoz<br />

Watson India<br />

10


Case Studies<br />

Finished Dosage Forms<br />

SOLID ORAL FACILITY<br />

Glenmark Generics Ltd., Goa, India<br />

This US FDA approved facility has a total built up area of 14800 Sq.m.<br />

comprising of a utility block and main manufacturing block complete<br />

with processing areas, quality control laboratory, warehouse,<br />

personnel gowning areas and service areas for air handling units and<br />

purified water generation and distribution system. This facility was<br />

constructed in a phase-wise manner over a period of 24 months.<br />

The facility has five lines for manufacture of Tablets. Each line<br />

comprises of multiple suites for granulation, drying, blending,<br />

compression, and coating. The facility has a central packing area with<br />

provision for blister (Alu-PVC, Alu-Alu), and Bulk Packing.<br />

The construction activities during the expansions were planned in such<br />

a manner that at no time there was stoppage of production. Necessary<br />

measures to minimize the interference with the ongoing operations<br />

were adopted.<br />

SCOPE OF SERVICES:<br />

·Basic Engineering, Detail Engineering, Commissioning<br />

& Start Up<br />

SOLID ORAL & LIQUID ORAL FACILITY<br />

Aurobindo Pharmaceuticals Ltd. , Hyderabad, India<br />

This US FDA approved facility was built on a green-field site. The<br />

facility comprises of two four-storey blocks built adjacent to each<br />

other and interconnected through corridors on each floor.<br />

The total constructed area of the production blocks is 26000 sq<br />

meters inclusive of Warehouse and personnel gowning areas. The<br />

facility was built in a time span of 18 months. The blocks have<br />

manufacturing sections for three finished dosage forms viz. Tablets,<br />

Dry Powder Suspensions and Liquid Syrup Suspensions.<br />

SCOPE OF SERVICES:<br />

Concept Design, Basic Engineering, Detail Engineering,<br />

Procurement Assistance, Site Audits, Commissioning &<br />

Start Up<br />

The manufacturing section comprise of 7 Granulation suites, 8 Tablet<br />

Compression suites, 7 Coating suites, 6 Packing lines, 1 line for Dry<br />

Syrups and 1 line for Liquid Syrups. Facility designed as a multistorey<br />

facility with intermediate flow of materials by gravity. This<br />

allows effective utilization of ground space.<br />

11


Case Studies<br />

Finished Dosage Forms<br />

SOLID ORALS & INJECTABLE FACILITY (ONCOLOGY)<br />

Shilpa Medicare Ltd. (Raichem LifeSciences), Hyderabad, India<br />

The facility is designed to meet the regulatory requirements of<br />

international bodies such as US FDA, UK MHRA, Australian TGA,<br />

Brazilian ANVISA, PMDA Japan. The entire development comprises of 7<br />

separate blocks spread over 27000 Sq.M. of plot. The structures planned<br />

include Oral Solids block, Injectable Block, R & D Block, Quality Control &<br />

Quality Assurance Block, Administration Block, Canteen, Utility Block,<br />

and other ancillaries like Security cabin, Pump rooms, ETP, etc.<br />

SCOPE OF SERVICES:<br />

Concept Design,<br />

Basic Engineering,<br />

Detailed Engineering,<br />

Containment Strategies,<br />

Procurement Assistance,<br />

Construction Management<br />

SOLID ORAL FACILITY (HORMONES)<br />

Glenmark Generics Ltd., Goa, India<br />

This US FDA approved facility was built on a green-field site and<br />

comprised of two-storey production block along with other ancillary<br />

blocks.<br />

The production block has a pilot plant and a commercial scale<br />

manufacturing section for hormones in Tablet Form. The total built up<br />

area of the is 4830 sq meters which houses pilot plant, commercial<br />

scale manufacturing section, packaging section, warehouse, personnel<br />

gowning areas, technical area for AHUs and routing of services, Quality<br />

control laboratories and administration offices.<br />

The facility was built in a time frame of 10 months. The plant was<br />

designed with a prime emphasis on product, personal & environmental<br />

safety. Layout was prepared to allow unidirectional movement of<br />

material and personnel and minimize potential mix-ups. The main<br />

manufacturing areas were maintained at negative pressure with<br />

respect to peripheral socially clean corridor.<br />

SCOPE OF SERVICES:<br />

Concept Design, Basic Engineering, Detail Engineering,<br />

Procurement Assistance, Construction Management,<br />

Commissioning & Start Up, Validation Support<br />

12


PROJECT COVERAGE<br />

GEORGIA<br />

CONGO<br />

MALAYSIA<br />

INDONESIA<br />

Note: The locations marked are only indicative


Case Studies<br />

Finished Dosage Forms<br />

PILOT PLANT (HI-POTENT PRODUCTS)<br />

Janssen Cilag Pharmaceuticals, (Johnson & Johnson), Mumbai, India<br />

This Pilot Scale Manufacturing facility for Solids, Liquids & Ointments was set up in a time span of 20 months.<br />

The facility is designed for handling PBOEL 3B compounds. It is proposed to be one of J&J's prime facilities for handling high potent<br />

formulations. Though the facility was a green field project, the constraint was that it was set up in an existing manufacturing site of<br />

SCOPE OF SERVICES:<br />

Concept Design<br />

Basic Engineering<br />

Detail Engineering<br />

Procurement Assistance<br />

Site Audits<br />

Construction Management<br />

Commissioning & Start Up<br />

Validation Support<br />

Janssen Cilag in Mumbai. This site is<br />

located within a largely residential area of<br />

Mumbai, and there were lots of restrictions<br />

as far as usable ground space, height,<br />

environmental protection etc. were<br />

concerned.<br />

The facility consists of the following main<br />

sections Ware House, Development Lab,<br />

Pre Formulation Scale Manufacturing, Pilot<br />

Scale manufacturing. Approximate built up<br />

area of the facility is 2000 Square Meters.<br />

The facility is a Ground plus three-storied<br />

structure.<br />

LIQUID & FREEZE DRIED INJECTABLE FACILITY (ONCOLOGY)<br />

Glenmark Generics Ltd., Pilar, Argentina<br />

The facility was designed to produce Liquid and Freeze Dried Oncology<br />

Injectables. The facility was designed on a green-field site of about<br />

10000 Sq.M. The main block is designed as a two storey building with<br />

Production area, Warehouse, Personnel Gowning areas housed on the<br />

Ground Floor and the Quality Assurance and Quality Control sections<br />

housed on the First Floor.<br />

The Vial Filling line and Freeze Drier have been procured from leading<br />

manufacturers in Europe. Clean room panels, HVAC items, Hi-Purity<br />

water generation and distribution systems and other process<br />

equipments have been supplied from India to reduce the project cost.<br />

The AHUs have Bag-In Bag-Out type filter arrangement to avoid<br />

exposure of operator to potent dust while replacing the filter. The<br />

process effluents generated are first deactivated and then released into<br />

the main effluent treatment plant. The exhaust air from various systems<br />

is filtered thru ULPA filters prior to release in to the atmosphere.<br />

SCOPE OF SERVICES:<br />

Concept Design, Basic Engineering, Detail Engineering,<br />

Procurement Assistance, Construction Management,<br />

Commissioning & Start Up, Validation Support<br />

14


Case Studies<br />

Finished Dosage Forms<br />

METERED DOSE INHALERS<br />

Glenmark Pharmaceuticals Ltd., Baddi, India<br />

The facility is designed to produce 'Metered Dose Inhalers' and<br />

has a total built up area of about 3500 Sq.M. The main block is<br />

designed as a three floor structure and houses Production<br />

area, Stores, Personnel Gowning areas and a compact Quality<br />

Control section.<br />

The MDI Filling line has been procured from DH Industries<br />

(Pamasol), UK. The line has an arrangement for single and<br />

double stage propellant filling of containers. HFA 134a will<br />

be used as propellant.<br />

<strong>SPECTRUM</strong> was involved in developing Process P&IDs<br />

including P&IDs for transfer of pressurized HFA, URS for<br />

Process Vessels and in the process has gained valuable<br />

exposure to special design requirements of such facilities. The<br />

layout is planned in a manner so as to enable modular<br />

expansion of the facility to accommodate second filling line in<br />

future.<br />

SCOPE OF SERVICES:<br />

Concept Design, Basic Engineering, Detail<br />

Engineering, Procurement Assistance, Construction<br />

Management, Commissioning & Start Up.<br />

INSULIN INJECTABLES, ORAL SOLIDS &<br />

CEPHALOSPORINE POWDER INJECTABLE FACILITY<br />

M J Biopharm, Navi Mumbai, India<br />

SCOPE OF SERVICES:<br />

Concept Design<br />

Basic Engineering<br />

Detail Engineering<br />

Procurement Assistance<br />

Validation Support<br />

The facility was built with technical support of Eli-Lily, USA.<br />

<strong>SPECTRUM</strong>'s personnel visited US plant of Eli-Lily to understand<br />

manufacturing operations prior to design of the facility.<br />

The entire development comprises of 3 separate buildings spread<br />

over 25000 Sq.M. of plot with the main block housing manufacturing<br />

sections for Insulin Injectables. The Cephalosporine Dry Powder<br />

Injectables are produced in a dedicated block and houses its own<br />

manufacturing, warehousing and personnel gowning sections.<br />

Built in a time span of 18 months, this Facility is approved by UK<br />

MHRA, South African MCC, Brazil ANVISA.<br />

15


Case Studies<br />

Finished Dosage Forms<br />

LARGE VOLUME PARENTERALS FACILITY<br />

JSC Eastpharm, Vladivostok, Russia<br />

The project involved setting up facility for producing Large<br />

Volume Parenterals and associated testing laboratories at<br />

Vladvostok in Russia. The facility was planned in accordance to<br />

cGMP requirements of WHO.<br />

<strong>SPECTRUM</strong> was involved in sizing and selection of process<br />

Detail Engineering<br />

equipment and <strong>SPECTRUM</strong>'s scope included developing<br />

Procurement Assistance<br />

concept designs, basic engineering and detailed engineering.<br />

Construction Management<br />

Systems such as Modular Clean room panels, HVAC, Process<br />

Validation Assistance<br />

Equipment, Generation and Distribution systems for Purified<br />

Water, WFI, Pure Steam were supplied from India.<br />

Phase I of the project, has an annual installed capacity of 12 Million bottles of 500 ml fill volume whereas the Phase II of the project<br />

augmented the annual capacity by additional 8 Million bottles of 100 ml fill volume.<br />

16<br />

SVP with BFS MACHINE, PENICILLIN & CEPHALOSPORIN DRY<br />

POWDER INJECTABLES FACILITY and GENERAL ORAL SOLIDS FACILITY<br />

SCOPE OF SERVICES:<br />

Concept Design<br />

Basic Engineering<br />

Detail Engineering<br />

Procurement Assistance<br />

SCOPE OF SERVICES:<br />

Concept Design<br />

Basic Engineering<br />

JSC Pharmasyntez, Irkutsk, Russia<br />

The project involved setting up facilities for manufacturing SVP with BFS<br />

machine for Water for Injection & Opthalmic products, General Oral<br />

Solids, Penicillin Dry Powder Injectables and Cephalosporin Dry Powder<br />

Injectables. The facilities were planned in an existing building and were<br />

set up in accordance to cGMP requirements of WHO.<br />

Unique feature of engineering was design of HVAC systems for sub-zero<br />

temperatures of up to (– 40) deg.C. This required Humidification as the<br />

humidity levels would fall to very low levels during winters. Systems such<br />

as HVAC, Process Equipment, Generation and Distribution systems for<br />

Purified Water, WFI, Pure Steam were supplied from India.<br />

The project provided insight in to how project were executed in countries<br />

of erstwhile Soviet Republic. It would typically involve preparing and<br />

submitting project drawings and documents to a local project institute<br />

who were the only ones authorized to design projects in Russia. The<br />

institute would then translate all drawings in local language and then<br />

issue the same to contractors for execution.<br />

We have installed Rommelag 321 for manufacturing of ampoules for Water for Injection and ophthalmic products with BFS<br />

technology. Machine has annual output 12.0 Million with one shift a day.


Case Studies<br />

Finished Dosage Forms<br />

INJECTABLE FACILITY (HORMONES)<br />

SANZYME LTD, SHAMEERPET, HYDERABAD India<br />

SCOPE OF SERVICES:<br />

Concept Design<br />

Basic Engineering<br />

Detail Engineering<br />

Procurement Assistance<br />

Construction Management<br />

Validation Support<br />

The facility is designed to meet the regulatory<br />

requirements of international bodies such as US FDA,<br />

UK MHRA. The entire development comprises of 3<br />

separate blocks spread over 15300 Sq.M. of plot. The<br />

structures planned include Injectable Block, Bio Lab,<br />

Utility Block, and other ancillaries like Security cabin,<br />

Pump rooms, ETP, etc.<br />

The salient design features of the facility include:<br />

<br />

<br />

<br />

<br />

<br />

Combi line (Vial and Ampoule) for Hormonal Injections and with Lyophilization.<br />

Dedicated Bio Animal Lab planned in the Plot<br />

Construction of Process areas with Clean room Modular panels.<br />

Clean Utility system consists of Purified water, Water for Injection and Pure steam planned for the Injectable plant.<br />

Effluent deactivation prior to discharge to the main ETP.<br />

SOLID ORALS & INJECTABLE FACILITY (ONCOLOGY)<br />

Neapolis Pharma,Tunisia (Part of Medis Group)<br />

The facility is designed to produce Oral Solids and Liquids<br />

and Freeze Dried Injectables. The facility is designed in<br />

accordance with regulatory requirements of EU GMP.<br />

The salient design features of the facility include –<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

Isolators for Active Sampling & Dispensing, Solution<br />

preparation for Injectables.<br />

Single Pot Processor Technology for Granulation.<br />

Contained transfer systems for Compression &<br />

Coating machines.<br />

Bag-in Bag-out filters for AHUs.<br />

Pre-engineered concrete building.<br />

Construction of Process areas with Clean room<br />

panels.<br />

Effluent deactivation system prior to discharge to the<br />

main ETP.<br />

SCOPE OF SERVICES:<br />

Concept Design, Basic Engineering,<br />

Detail Engineering, Procurement<br />

Assistance, Commissioning<br />

Assistance, Validation Support<br />

17


Case Studies<br />

Finished Dosage Forms<br />

LAB and R&D FACILITY<br />

Novartis Healthcare Pvt. Ltd., Thane, India<br />

<strong>SPECTRUM</strong> designed and engineered a global research &<br />

development laboratory & pilot scale manufacturing facility for<br />

Novartis healthcare.<br />

SCOPE OF SERVICES:<br />

Project Management<br />

The main sections built in the center were:<br />

Basic Engineering<br />

Analytical Laboratory<br />

Detail Engineering<br />

Wet Chemistry Lab<br />

Procurement Assistance<br />

Pilot Plant for OSD, Liquids & Semisolids.<br />

Inspection & Expediting<br />

Stability Chambers' section<br />

Offices for Chemists<br />

Construction Management<br />

Utility Area<br />

Validation Support<br />

The Project was done in existing building. Approximate area of<br />

he facility is 12,500 Square feet. Facility was planned to<br />

accommodate 25 Chemists. All utilities such as Lab Gases & Air compressors were located on Terrace. The major constraint in the<br />

project was that the Lab was located on 5th floor & all the utilities had to pass through the 6th floor to reach the Labs.This project was<br />

completed in record time of 10 Months and was appreciated as a state of the art facility & was qualified by Novartis, Switzerland's<br />

Quality Control Department<br />

MULTIPLE DOSAGE FORMULATION FACILITY<br />

Ethiopian Pharmaceuticals Ltd., Addis Ababa, Ethiopia<br />

Ethiopian Pharmaceutical Manufacturing (EPHARM), fully owned by national government of Ethiopia, is the largest manufacturer<br />

of Finished Dosage Formulations in Ethiopia. Epharm was planning to set up new manufacturing facilities in accordance with<br />

cGMP requirements of WHO and had a requirement of carrying out Project Feasibility study before the initiative was taken further.<br />

SCOPE OF SERVICES:<br />

Capacity Planning, Conceptual Design, Basic Engineering ,<br />

Project Costing, Project Implementation Strategy<br />

18<br />

<strong>SPECTRUM</strong> partnered with Industrial Project Services (IPS) of Ethiopia<br />

to conduct this study. <strong>SPECTRUM</strong>'s scope comprised of Capacity<br />

Planning for all dosage forms based on Market Study reports and<br />

Category of Products proposed by IPS. This was followed by sizing of<br />

Production batches, recommending equipment capacities and preparing<br />

facility layouts in accordance with GMP. The final capacities and facility<br />

sizes were again reviewed based on the feasibility of accommodating<br />

these blocks in the piece of land already available with Epharm.<br />

The facilities or structures planned included Oral Solids Block for<br />

General Products, Penicillin Block, Large Volume Parenteral Block, Oral<br />

Liquids and Suspensions Block, Cephalosporin Block and Dermatology<br />

formulation block. In addition to this a Central Warehouse,<br />

Administration, Quality Control, Quality Assurance, R & D and Utility<br />

Blocks were also planned. The total planned built up area was about<br />

55,000 Sq. M.


Case Studies<br />

Finished Dosage Forms<br />

SCOPE OF SERVICES:<br />

Project Management<br />

Basic Engineering<br />

Detail Engineering<br />

Procurement Assistance<br />

Inspection & Expediting<br />

Construction Management<br />

Validation Support<br />

RUBBER COMPOUNDS PRODUCING FACILITY<br />

Helvoet Pharma India Operation Pvt. Ltd., Near Pune, India<br />

Helvoet Pharma, a Belgium based enterprise and part of the<br />

Datwyler Group is one of the leading producers of Packaging<br />

products for the Pharmaceutical industry in the world. This is<br />

their first manufacturing plant in India.<br />

The facility produces rubber components in the form of<br />

Closures to be used in the Pharmaceutical industry. The facility<br />

has sections for Rubber Mixing, Milling, Extrusion, Moulding,<br />

Trimming, Washing and Packaging. Since the product being<br />

produced was meant for use in pharmaceutical applications,<br />

the environment in the washing sections of the facility were<br />

classified and maintained in line with the cGMP standards<br />

prevalent in the Pharmaceutical industry. The process water used in the final stages of washing of the components met the USP<br />

standard of Purified Water and Water for Injection. In addition there were storage areas for Raw Materials, Packaging Material,<br />

Finished products and Solvents, Quality Control laboratory, Administration offices, Maintenance areas, etc.<br />

SOLID ORALS & INJECTABLE FACILITY (ONCOLOGY)<br />

Naprod Life Sciences Pvt. Ltd., Tarapur, India<br />

The facility comprised of a compact manufacturing block<br />

with Dispensing and Manufacturing areas admeasuring<br />

only 1000 Sq.M. The facility has received ANVISA<br />

approval.<br />

The production block has manufacturing sections for<br />

Freeze-Dried Injectables and Oral Solids in the form of<br />

Tablets and Capsules.<br />

Dispensing of Actives and Solution Compounding for<br />

Injectables is done inside Isolators. Personnel Protective<br />

Gowns are planned for personnel working in other parts of<br />

the manufacturing areas where they handle potent<br />

material. The main manufacturing areas were maintained<br />

at negative pressure with respect to peripheral socially<br />

clean corridor. The process effluents generated are first<br />

deactivated and then released into the main effluent<br />

treatment plant.<br />

SCOPE OF SERVICES:<br />

Concept Design, Basic Engineering, Detail Engineering,<br />

Validation Support<br />

19


Case Studies<br />

Finished Dosage Forms<br />

PHARMA CLUSTER<br />

JSC Humanity, Tbilisi, Georgia<br />

The ongoing facility is designed to meet the regulatory requirements of<br />

international bodies such as EU GMP.<br />

The entire development comprises of 9 separate blocks with total built up<br />

area of 29000 Sq. Mtr. Facility has been planned in existing structures.<br />

The structures planned include Repackaging for General products,<br />

Repackaging for Oncology and Hormone products, Repackaging of<br />

Cephalosporin products, Full manufacturing for Oral solid dosage form,<br />

Central warehouse, Central Quality control laboratory, and<br />

Administration & QA, Utility and HT yard. The projected cost of the entire<br />

development is USD 30 Million.<br />

The salient design features of the facility include:<br />

Pre-Engineered Metal Building construction for the new buildings of<br />

Full line Oral solid dosage form for faster construction.<br />

Central warehouse is planned for storage of 10,000 pallets with selfsupported<br />

ASRS.<br />

Existing structures are refurbished to meet the GMP requirement.<br />

Construction of Process areas with Clean room panels.<br />

Effluent deactivation prior to discharge to the main ETP. .<br />

SCOPE OF SERVICES:<br />

Master Planning, Concept Design, Basic Engineering,<br />

Detail Engineering, Procurement Assistance,<br />

Construction Management, Validation Documentation,<br />

QMS Development & Implementation<br />

SOLID ORAL FORMULATION FACILITY<br />

Pharmax pharmaceuticals, Dubai, UAE<br />

The Facility is designed for manufacturing Oral Solid Dosage<br />

formulations under General category with plans to expand and set up<br />

facilities for the other pharmaceutical dosages in near future. The<br />

Facility is planned in plot of approx. 8715.60 Sq. M. in the industrial<br />

area at Duboitech, Dubai. The facility is designed in compliance with<br />

requirements of the various local authorities like DEWA, DM, and<br />

DCDA, etc and designed to meet cGMP requirements of regulatory<br />

bodies like US FDA, EU and GCC.<br />

SCOPE OF SERVICES:<br />

Master Planning, Conceptual Design, Basic Engineering ,<br />

Detail engineering, procurement assistance, Commissioning<br />

assistance, Documentation & validation Support<br />

When fully operational, this Oral Solid Dosage facility will be capable<br />

of producing 195 million tablets per year & 10 million Capsules (Hard<br />

Gelatine) per year.<br />

The core areas are planned in Modular Panels. The Cooling system is<br />

designed considering the District Cooling system.<br />

20


Case Studies<br />

Finished Dosage Forms<br />

ONCOLOGY OSD & GENERAL OSD FACILITY<br />

Novast Laboratories Ltd., Nantong, China<br />

The project comprises of two separate blocks for producing Oral Solid<br />

Dosage formulations for General and Oncology category of products.<br />

The planned annual capacity of the General products facility is about<br />

2 billion units and that of Oncology products facility is about 70 million<br />

units. The facility has been set up in accordance with regulatory<br />

guidelines of US FDA and other local statutory norms for safety and<br />

building construction regulation.<br />

SCOPE OF SERVICES:<br />

Concept Design, Containment Strategy (For Oncology Facility),<br />

Basic Engineering, Detail Engineering, Procurement Assistance<br />

(For Oncology Facility Process Equipment), Construction<br />

Supervision, Documentation & Validation Support<br />

The Oncology facility has its dedicated Store and Quality Control<br />

departments whereas the General products facility shares these<br />

services with the other existing blocks.<br />

Spectrum on this project worked in coordination with a local design<br />

firm, who supported in development of Structural and Fire Safety<br />

designs as per local codes and supported Novast in applying and<br />

getting required statutory approvals.<br />

VACCINE FILL FINISH FACILITY<br />

A.J. Biologics, Malaysia<br />

This is the first Vaccine production facility coming up in<br />

Malaysia. The proposed facility will be planned, designed,<br />

engineered and operated as per current cGMP standards<br />

of international regulatory authorities of EMEA, PIC/S as<br />

well as conform to all local regulatory requirements.<br />

The facility will be designed to produce liquid injectable in<br />

vials and pre-filled syringes and lyophilised injectable in<br />

vials. The facility will be capable of producing 12.5 million<br />

vials per year of liquid injections, 10 million vials per year of<br />

lyophilised injections and 10 million syringes per year of<br />

liquids in pre-filled syringes.<br />

The facility will also have proper storage units for raw<br />

materials, finished product storage prior to shipment and<br />

other spares and consumables. A proper laboratory<br />

system is also planned to allow quality assurance, quality<br />

control and in-process quality control activities to be<br />

conducted as per regulatory guidelines.<br />

SCOPE OF SERVICES:<br />

Concept Design, Basic Engineering, Detail Engineering,<br />

Procurement Assistance, Project Management, Site Supervision,<br />

Commissioning & Startups, Documentation & Validation Support<br />

21


Case Studies<br />

Biopharmaceuticals<br />

SCOPE OF SERVICES:<br />

Project Management<br />

Basic Engineering<br />

Detailed Engineering<br />

Procurement Assistance<br />

ANIMAL FEED ENZYME PRODUCTION FACILITY<br />

TexBioscience Pvt. Ltd., Chennai, India.<br />

TexBioscience is one of the leading producers of enzymes<br />

and has production facilities for textile and animal feed<br />

enzyme.<br />

The facility will be designed as multi-purpose facility to<br />

facilitate manufacturing of animal feed enzymes based on<br />

bacterial and fungal culture. The facility will be designed to<br />

meet HACCP guidelines applicable for Animal feed<br />

manufacturing.<br />

The facility has two separate culture development and<br />

fermentation sections, one each for Fungal and Bacterial<br />

fermentation. There are two 20 KL production fermenters in<br />

each module. The downstream processing involves<br />

Harvesting, Filter Press, Centrifuge as one line and Microfiltration and Spray Drying as the other line. The final enzyme is blended with<br />

diluent and packed.<br />

VACCINE PRODUCTION FACILITY<br />

BIOLOGICAL E. LTD., Hyderabad, India.<br />

Biological E. was established over 50 years ago. It is the first private sector biological products company in India and the first<br />

pharmaceuticals company in South India. BE is also the pioneer in preventive medicine.<br />

The facility will be designed as multi-purpose facility to facilitate manufacturing of bulk vaccines on campaign basis. The facility will be<br />

designed for 100 million doses/ year of each bulk vaccine under cGMP conditions. Required unit operations such as cell propagation,<br />

incubation, Virus infection, virus incubation, harvesting, Media preparation and storage.<br />

The facility will be designed in accordance of containment requirement for managing infectious agents of BSL 2 category. The design<br />

objective is to protect the operators and others from exposure and also to protect the outside environment from potentially<br />

hazardous/infectious agents.<br />

SCOPE OF SERVICES:<br />

Project Management, Basic Engineering , Detailed Engineering, Procurement Assistance, Validation Support<br />

22


Case Studies<br />

Biopharmaceuticals<br />

FERMENTATION FACILITY<br />

Sanzyme Ltd.,Near Hyderabad, India<br />

SCOPE OF SERVICES:<br />

Basic Engineering<br />

Detail Engineering<br />

Procurement Assistance<br />

Site Supervision Support<br />

Validation Support<br />

The facility produces various types of Probiotics. The facility<br />

is designed to meet the internal standards and international<br />

regulatory requirements. Two dedicated blocks one for<br />

probiotic and one for Lactic acid bacillus (LAB block) were<br />

planned in the plot. In addition there block specific areas for<br />

Raw Materials, Packaging Material, Finished products and<br />

Solvents. The support infrastructure such as Quality Control<br />

laboratory, Administration offices, Maintenance areas, ETP,<br />

Utility block, etc. are common for both the block.<br />

INSULIN PRODUCTION FACILITY<br />

Wockhardt. Ltd., Aurangabad, India.<br />

Wockhardt Ltd is one of the leading Pharmaceutical and<br />

Biotech manufacturer in India and also has manufacturing<br />

facilities in US and UK. This facility was the expansion of<br />

their existing facility named as “Plant D, Phase-I”.<br />

The process involved for the LAB block includes<br />

fermentation, separation, drying (Spray drier) and powder<br />

processing. Powder processing area is designed as clean room and having control and monitoring of air as per ISO 8 requirement for<br />

HVAC system.Purified water as per USP grade was installed and was used for cleaning and rinsing of production equipment.<br />

Fermenters, three in numbers of 25KL each were installed in LAB block.<br />

The proposed facility was planned, designed and<br />

engineered as per cGMP standards and shall confirm to all<br />

relevant local statuary/regulatory and c G M P<br />

requirements. The design was done considering phase-II<br />

& phase-III expansions in future. The facility has two sets<br />

of 20 KL, 2KL, 0.2KL & 0.02 KL fermenters & 2 Nos. of 7<br />

KL Harvesters. The layout was planned as G+2 structure<br />

with service area on terrace. Modular & Aerocon panels<br />

were used on all the floors to ease dismantling and<br />

expansion of facility. The utility equipment's were located<br />

on terrace to reduce on pumping energy & associated<br />

piping inventory.<br />

SCOPE OF SERVICES:<br />

Review of Conceptual Design, Basic Engineering , Detail<br />

Engineering, Procurement Assistance, Validation Support<br />

23


Case Studies<br />

Active Pharmaceutical Ingredients<br />

CEPHALOSPORIN CRYSTALLINE STERILE BULK FACILITY<br />

Parabolic Drugs Limited, Derabassi, Punjab.<br />

The facility is designed to produce<br />

'Cephalosporin Crystalline Sterile Bulk' and<br />

has a total built up area of about 1600 Sq.M.<br />

The main block is designed as a ground plus<br />

two storey structure with warehouse and<br />

production area on Ground floor, Technical<br />

area for placement of AHU on first floor and<br />

Utility area on second floor<br />

SCOPE OF SERVICES:<br />

Concept Design, Basic Engineering, Detail Engineering,<br />

Procurement Assistance,<br />

The operations carried out in the sterile area<br />

i.e. from crystallization step onwards thru to<br />

Drying, Filling and Packing is fully<br />

automated and is procured from Omca<br />

Plants Srl. (BA.DO.), Italy.<br />

MULTI PRODUCT SMALL SCALE PRODUCTION & KILO LAB FACILTY<br />

Enaltec Labs, Ambernath, India<br />

The facility was designed as a Multi-Product Small Scale<br />

Production & Kilo Lab facility for manufacturing APIs.<br />

The proposed facility was planned, designed and engineered as<br />

per cGMP standards of international authorities like USFDA,<br />

WHO etc. and confirms to all relevant local statuary/regulatory<br />

and cGMP requirements. The facility design complies with ICH,<br />

NFPA & ISPE guidelines. The facility has eventually received<br />

approval by USFDA.<br />

The project comprised of setting up of Production Block,<br />

Warehouse & Quality Control Block. In addition, the facility has<br />

all necessary ancillary structures like Utility Block, Solvent Drum<br />

Yard, Transformer Yard and Effluent treatment plant.<br />

SCOPE OF SERVICES:<br />

Basic Engineering , Detail Engineering, Procurement<br />

Assistance, Inspection & Expediting, Construction<br />

Management, Validation Support<br />

24


Case Studies<br />

Active Pharmaceutical Ingredients<br />

VITAMIN D3 & ALLIED PRODUCTS FACILITY<br />

Fermenta Biotech, Dahej, India<br />

The scope commenced with Site Master<br />

Planning for setting up of blocks for all<br />

production stages of Vitamin D3, in phases.<br />

The entire project was envisioned to be<br />

developed in four phases commencing with<br />

setting up of API facility in the first phase<br />

with backward integration to Fermentation<br />

facility in the fourth phase.<br />

The overall site to be developed is about<br />

28,000 Sq.M with a total constructed area<br />

of 3000 Sq.M in the first phase. The first<br />

phase of the project was completed in 12<br />

months.<br />

SCOPE OF SERVICES:<br />

Master Planning, Basic Engineering, Detail Engineering, Procurement<br />

Assistance, Site Audits, Construction Management, Commissioning & Start<br />

Up , Validation Support<br />

API FACILITY (HORMONE)<br />

Dr. Reddy's Laboratories (DRL), Vizag, India<br />

The Hormone Manufacturing facility was constructed on an existing<br />

site of DRL. Area of production block is approx. 1500 Sq.M with a<br />

capacity of 50 Kgs/ month. The project cost was completed in 10<br />

months.<br />

The facility has two dedicated self-contained modules for<br />

manufacturing two products simultaneously. The facility was design<br />

for PBOEL (Performance Based Operator Exposure Limit) of 500<br />

ng/cu.m. Based on this risk assessment Containment levels were<br />

decided. Dedicated detoxification reactor is provided to detoxify the<br />

effluent before discharging it to a common Effluent Treatment Plant.<br />

SCOPE OF SERVICES:<br />

Concept Design , Basic Engineering, Detail Engineering,<br />

Procurement Assistance, Site Supervision, Commissioning &<br />

Start up, Validation & Documentation Support<br />

<strong>SPECTRUM</strong> provided critical inputs during planning stage to<br />

minimize handling of potent product in powder form. The risk<br />

elimination at source technique was used minimizing operator<br />

interface. This facility has been approved by USFDA.<br />

25


Spectrum PharmaTECH<br />

Consultants Pvt. Ltd.<br />

Address:<br />

503, Dosti Pinnacle<br />

Plot E-7, Road No. 22, Wagle Estate<br />

Thane (West)- 400607, India<br />

Tel: +91-22-21580500, Fax: +91-22-21580505<br />

E-mail: engg@spectrumpharmatech.com<br />

Web Site: www.spectrumpharmatech.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!